Review of KRYSTAL 1b and Role of Adagrasib in Patients With Untreated CNS Metastases

Mark Socinski, MD and Joshua Sabari, MD review the key efficacy data from the KRYSTAL 1b cohort and discusses strategies for managing adverse events seen with adagrasib.

Related Videos
Expert on lung cancer
Expert on NSCLC
Expert on NSCLC
Expert on NSCLC
Chandler H. Park, MD, an expert on renal cell carcinoma
Edward B. Garon, MD, MS, an expert on lung cancer
Related Content